Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1029081

The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion


Dembitz, Vilma; Tomić, Barbara; Kodvanj, Ivan; Simon, Julian; Bedalov, Antonio; Visnjic, Dora
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion // The Journal of biological chemistry, 294 (2019), 42; 15257-15270 doi:10.1074/jbc.RA119.009396 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1029081 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion

Autori
Dembitz, Vilma ; Tomić, Barbara ; Kodvanj, Ivan ; Simon, Julian ; Bedalov, Antonio ; Visnjic, Dora

Izvornik
The Journal of biological chemistry (0021-9258) 294 (2019), 42; 15257-15270

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
AICAr ; Chk1 ; AML ; leukemia ; cell differentiation ; DNA damage response ; AMP-activated kinase (AMPK) ; nucleotide cell ; cycle pyrimidine

Sažetak
Metabolic pathways play important roles in proliferation and differentiation of malignant cells. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAr), a precursor in purine biosynthesis and a well-established activator of AMP-activated protein kinase (AMPK), induces widespread metabolic alterations and is commonly used for dissecting the role of metabolism in cancer. We have previously reported that AICAr promotes differentiation and inhibits proliferation of myeloid leukemia cells. Here, using metabolic assays, immunoblotting, flow cytometry analyses, and siRNA-mediated gene silencing in leukemia cell lines, we show that AICAr-mediated differentiation was independent of the known metabolic effects of AMPK, including glucose consumption, but instead depends on the activation of the DNA damage-associated enzyme checkpoint kinase 1 (Chk1) induced by pyrimidine depletion. LC/MS/MS metabolomics analysis revealed that AICAr increases orotate levels and decreases uridine monophosphate (UMP) levels, consistent with inhibition of UMP synthesis at a step downstream of dihydroorotate dehydrogenase (DHODH). AICAr and the DHODH inhibitor brequinar had similar effects on differentiation markers and S-phase arrest, and genetic or pharmacological Chk1 inactivation abrogated both of these effects. Our results delineate an AMPK-independent effect of AICAr on myeloid leukemia differentiation that involves perturbation of pyrimidine biosynthesis and activation of the DNA damage response network.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
--KK.01.1.1.01.0007 - Znanstveni centar izvrnosti - Eksperimentalna i klinička istraživanja hipoksijsko-ishemijskog oštećenja mozga u perinatalnoj i odrasloj dobi (ZCI - NEURO) (Judaš, Miloš) ( CroRIS)
--IP-2016-06-4581 - Signalni mehanizmi i metaboličke promjene u diferencijaciji stanica akutne mijeloične leukemije (SignalmetabAML) (Višnjić, Dora) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Vilma Dembitz (autor)

Avatar Url Ivan Kodvanj (autor)

Avatar Url Barbara Tomić (autor)

Avatar Url Dora Višnjić (autor)

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada doi www.jbc.org

Citiraj ovu publikaciju:

Dembitz, Vilma; Tomić, Barbara; Kodvanj, Ivan; Simon, Julian; Bedalov, Antonio; Visnjic, Dora
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion // The Journal of biological chemistry, 294 (2019), 42; 15257-15270 doi:10.1074/jbc.RA119.009396 (međunarodna recenzija, članak, znanstveni)
Dembitz, V., Tomić, B., Kodvanj, I., Simon, J., Bedalov, A. & Visnjic, D. (2019) The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion. The Journal of biological chemistry, 294 (42), 15257-15270 doi:10.1074/jbc.RA119.009396.
@article{article, author = {Dembitz, Vilma and Tomi\'{c}, Barbara and Kodvanj, Ivan and Simon, Julian and Bedalov, Antonio and Visnjic, Dora}, year = {2019}, pages = {15257-15270}, DOI = {10.1074/jbc.RA119.009396}, keywords = {AICAr, Chk1, AML, leukemia, cell differentiation, DNA damage response, AMP-activated kinase (AMPK), nucleotide cell, cycle pyrimidine}, journal = {The Journal of biological chemistry}, doi = {10.1074/jbc.RA119.009396}, volume = {294}, number = {42}, issn = {0021-9258}, title = {The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion}, keyword = {AICAr, Chk1, AML, leukemia, cell differentiation, DNA damage response, AMP-activated kinase (AMPK), nucleotide cell, cycle pyrimidine} }
@article{article, author = {Dembitz, Vilma and Tomi\'{c}, Barbara and Kodvanj, Ivan and Simon, Julian and Bedalov, Antonio and Visnjic, Dora}, year = {2019}, pages = {15257-15270}, DOI = {10.1074/jbc.RA119.009396}, keywords = {AICAr, Chk1, AML, leukemia, cell differentiation, DNA damage response, AMP-activated kinase (AMPK), nucleotide cell, cycle pyrimidine}, journal = {The Journal of biological chemistry}, doi = {10.1074/jbc.RA119.009396}, volume = {294}, number = {42}, issn = {0021-9258}, title = {The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion}, keyword = {AICAr, Chk1, AML, leukemia, cell differentiation, DNA damage response, AMP-activated kinase (AMPK), nucleotide cell, cycle pyrimidine} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE
  • Nature Index


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font